Safety and Immunogenicity of a Malaria Vaccine, Plasmodium falciparum AMA-1/MSP-1 Chimeric Protein Formulated in Montanide ISA 720 in Healthy Adults

Jinhong Hu, Zhihui Chen, Jun Gu et al. · 2008

Read Safety and Immunogenicity of a Malaria Vaccine, Plasmodium falciparum AMA-1/MSP-1 Chimeric Protein Formulated in Montanide ISA 720 in Healthy Adults by Jinhong Hu, Zhihui Chen, Jun Gu et al. (2008) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0001952.txt.

Description

Jinhong Hu and co-authors ran a first human safety test of a malaria vaccine in a 2008 PLOS ONE study. The vaccine is built from a fused protein that joins parts of two proteins from the malaria parasite, AMA-1 and MSP-1. In rabbits and monkeys, the fused protein raised antibodies that block the parasite.

The phase one trial gave the vaccine, mixed in an oily carrier called Montanide ISA 720, to healthy adults. It was randomized, partly blinded, and used a dummy dose for comparison, with doses raised in steps. First trials like this check safety and immune response before any test of real protection.

Catalog record

CREATORJinhong Hu, Zhihui Chen, Jun Gu et al.
YEAR2008
COLLECTIONPAPERS
FORMATTXT
FILE SIZE61 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0001952

Browse the full library · About the Tower of Babel